CABERGOLINE Side Effects

6654364-9 | Cardiac Disorder, Electrocardiogram Abnormal, Mitral Valve Incompetence, Palpitations, Tricuspid Valve Incompetence
on Mar 15, 2010 Female patient from JAPAN , 26 years of age, weighting 97.00 lb, was diagnosed with hyperprolactinaemia, menstruation irregular and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac disorder, electrocardiogram abnormal, mitral valve incompetence, palpitations, tricuspid valve incompetence. Cabergoline dosage: 0.25 Mg Daily, Once A Week.

6654121-3 | Blood Lactate Dehydrogenase Increased, Joint Swelling, Oedema Peripheral, Orthostatic Intolerance, Pleural Effusion, Pleural Fibrosis, Pulmonary Toxicity
Patient was taking Cabergoline (View Usage). Patient had the following side effects: blood lactate dehydrogenase increased, joint swelling, oedema peripheral, orthostatic intolerance, pleural effusion, pleural fibrosis, pulmonary toxicity on Mar 09, 2010 from SPAIN Additional patient health information: Male patient , 65 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: 4 Mg, Qd. During the same period patient was treated with L DOPA (LEVODOPA) (View L-dopa (levodopa) Review and L-dopa (levodopa) Label ), CARBIDOPA (CARBIDOPA) (View Carbidopa (carbidopa) Review and Carbidopa (carbidopa) Label ), BENSERAZIDE (BENSERAZIDE) (View Benserazide (benserazide) Review and Benserazide (benserazide) Label ), ENTACAPONE (ENTACAPONE) (View Entacapone (entacapone) Review and Entacapone (entacapone) Label ).

6641780-4 | Pneumocephalus
Adverse event was reported on Mar 15, 2010 by a Male patient taking Cabergoline (View Usage) (Dosage: ) . Location: BELGIUM , 43 years of age, After Cabergoline was administered, patient had the following side effects: pneumocephalus. Patient was hospitalized.

6640851-6 | Middle Insomnia, Nightmare, Sleep Disorder
on Mar 10, 2010 Female patient from JAPAN , 54 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: middle insomnia, nightmare, sleep disorder (What is sleep disorder?). Cabergoline dosage: .


6635311-2 | Pneumocephalus
on Mar 01, 2010 Male patient from BELGIUM , 43 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient had the following side effects: pneumocephalus. Cabergoline dosage: 0.5 Mg, Weekly.

6620795-6 | Bone Erosion, Pneumocephalus
Patient was taking Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: bone erosion, pneumocephalus on Feb 27, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 43 years of age, was diagnosed with hyperprolactinaemia and. Cabergoline dosage: 1/2 Mg Per Week. Patient was hospitalized.

6620328-4 | Middle Insomnia, Nightmare, Sleep Disorder
Adverse event was reported on Feb 24, 2010 by a Female patient taking Cabergoline (View Usage) (Dosage: ) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 54 years of age, Patient experienced the following unwanted or unexpected effects: middle insomnia, nightmare, sleep disorder (What is sleep disorder?).

6594896-5 | Bradykinesia, Gait Disturbance, Liver Disorder
on Feb 03, 2010 Male patient from JAPAN , 73 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient had the following side effects: bradykinesia, gait disturbance, liver disorder. Cabergoline dosage: . During the same period patient was treated with GLUTATHIONE (View Glutathione Review and Glutathione Label ), ENTACAPONE (View Entacapone Review and Entacapone Label ), L DOPA (Unk) (View L-dopa Review and L-dopa Label ). Patient was hospitalized.

6580172-3 | Pulmonary Toxicity
on Feb 05, 2010 Female patient from TURKEY , 78 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: pulmonary toxicity. Cabergoline dosage: Unk.

6578553-7 | Bradykinesia, Gait Disturbance, Liver Disorder
Patient was taking Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: bradykinesia, gait disturbance, liver disorder on Feb 03, 2010 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: . During the same period patient was treated with GLUTATHIONE (View Glutathione Review and Glutathione Label ), ENTACAPONE (View Entacapone Review and Entacapone Label ), L DOPA (Unk) (View L-dopa Review and L-dopa Label ). Patient was hospitalized.

6566767-1 | Cardiac Failure, Cardiac Valve Disease, Cardiomegaly, Mitral Valve Incompetence, Oedema, Pleural Effusion, Pulmonary Congestion, Weight Increased
Adverse event was reported on Jan 20, 2010 by a Female patient taking Cabergoline (View Usage) (Dosage: Unk) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 67 years of age, Patient had the following side effects: cardiac failure, cardiac valve disease, cardiomegaly, mitral valve incompetence, oedema, pleural effusion, pulmonary congestion, weight increased.

6534500-5 | Blood Prolactin Increased, Fatigue, Nausea
on Dec 30, 2009 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: blood prolactin increased, fatigue, nausea (What is nausea?). Cabergoline dosage: Frequency: Once A Week,.

6510537-7 | Mitral Valve Incompetence
on Dec 03, 2009 Male patient from TURKEY , 35 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: mitral valve incompetence. Cabergoline dosage: 1 Mg/day, Oral.

6485131-7 | Abortion Spontaneous
Patient was taking Cabergoline (View Usage). Patient had the following side effects: abortion spontaneous on Nov 20, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 24 years of age, was diagnosed with pituitary tumour benign and. Cabergoline dosage: 0.25 Mg - 2/1 Week.

6478699-8 | Aggression, Hypersexuality, Libido Increased, Pathological Gambling
Adverse event was reported on Nov 25, 2009 by a Male patient taking Cabergoline (View Usage) (Dosage: Unk Mg, Unk) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: GERMANY , 35 years of age, weighting 172.0 lb, After Cabergoline was administered, patient had the following side effects: aggression, hypersexuality, libido increased, pathological gambling. During the same period patient was treated with TREMARIT (Unk) (View Tremarit Review and Tremarit Label ).

6478235-6 | Hypersexuality, Libido Increased, Pathological Gambling, Sexual Abuse
on Nov 25, 2009 Male patient from GERMANY , 35 years of age, weighting 172.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: hypersexuality, libido increased, pathological gambling, sexual abuse. Cabergoline dosage: Unk Mg, Unk. During the same period patient was treated with TREMARIT (Unk) (View Tremarit Review and Tremarit Label ).

6436593-2 | Pericardial Effusion
on Oct 30, 2009 Female patient from JAPAN , 27 years of age, weighting 112.4 lb, was diagnosed with hyperprolactinaemia, menstruation irregular and was treated with Cabergoline (View Usage). Patient had the following side effects: pericardial effusion. Cabergoline dosage: Unk. During the same period patient was treated with PREMARIN (Unk) (View Premarin Review and Premarin Label ), NORLUTEN (Unk) (View Norluten Review and Norluten Label ). Patient was hospitalized.

6433228-X | Abnormal Behaviour, Aggression, Compulsive Shopping, Crime, Hypersexuality, Obsessive-compulsive Disorder, Paranoia, Pathological Gambling, Suicidal Ideation
Patient was taking Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: abnormal behaviour, aggression, compulsive shopping, crime, hypersexuality, obsessive-compulsive disorder (What is obsessive-compulsive disorder?), paranoia, pathological gambling, suicidal ideation on Oct 28, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 59 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: Unk.

6417337-7 | Pericardial Effusion
Adverse event was reported on Oct 15, 2009 by a Female patient taking Cabergoline (View Usage) (Dosage: Unk) was diagnosed with hyperprolactinaemia, menstruation irregular and. Location: JAPAN , 27 years of age, Patient experienced the following unwanted or unexpected effects: pericardial effusion. During the same period patient was treated with PREMARIN (Unk) (View Premarin Review and Premarin Label ), NORLUTEN (Unk) (View Norluten Review and Norluten Label ). Patient was hospitalized.

6389042-7 | Aortic Dilatation, Aortic Valve Incompetence, Echocardiogram Abnormal, Mitral Valve Incompetence, Mitral Valve Sclerosis
on Aug 21, 2009 Male patient from UNITED KINGDOM , 40 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient had the following side effects: aortic dilatation, aortic valve incompetence, echocardiogram abnormal, mitral valve incompetence, mitral valve sclerosis. Cabergoline dosage: 250 Mcg- 1/1 Week. During the same period patient was treated with ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ). Patient was hospitalized.

6371753-0 | Pregnancy Test False Positive
on Sep 08, 2009 Female patient from JAPAN , 24 years of age, was diagnosed with hyperprolactinaemia and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: pregnancy test false positive. Cabergoline dosage: 0.25 Mg, Weekly.

6368887-3 | Aortic Dilatation, Aortic Valve Incompetence, Echocardiogram Abnormal, Mitral Valve Incompetence, Mitral Valve Sclerosis
Patient was taking Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: aortic dilatation, aortic valve incompetence, echocardiogram abnormal, mitral valve incompetence, mitral valve sclerosis on Sep 09, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 40 years of age, was diagnosed with prolactinoma and. Cabergoline dosage: 250 Ug, Twice Weekly. During the same period patient was treated with ACETAZOLAMIDE (250 Mg, 2x/day) (View Acetazolamide Review and Acetazolamide Label ). Patient was hospitalized.

6368840-X | Abortion Spontaneous
Adverse event was reported on Sep 08, 2009 by a Female patient taking Cabergoline (View Usage) (Dosage: 0.5mg, Oral) was diagnosed with prolactinoma and. Location: UNITED KINGDOM , 36 years of age, Patient had the following side effects: abortion spontaneous.

6368821-6 | Acute Myocardial Infarction, Cardiac Aneurysm, Cardiac Valve Disease, Dyspnoea, Mitral Valve Incompetence, Ventricular Tachycardia
on Sep 08, 2009 Male patient from UNITED KINGDOM , 50 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: acute myocardial infarction, cardiac aneurysm, cardiac valve disease, dyspnoea, mitral valve incompetence, ventricular tachycardia. Cabergoline dosage: 0.5mg, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CO CODAMOL (View Co-codamol Review and Co-codamol Label ), CREON (View Creon Review and Creon Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized.

6340269-X | Echocardiogram Abnormal
on Aug 21, 2009 Male patient from UNITED STATES , 40 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: echocardiogram abnormal. Cabergoline dosage: 250 Mg,. Patient was hospitalized.

6338031-7 | Pulmonary Toxicity
Patient was taking Cabergoline (View Usage). Patient had the following side effects: pulmonary toxicity on Aug 20, 2009 from TURKEY Additional patient health information: Female patient , 78 years of age, . Cabergoline dosage: .

6335624-8 | Abortion, Pregnancy Test False Positive
Adverse event was reported on Aug 19, 2009 by a Female patient taking Cabergoline (View Usage) (Dosage: Unk) was diagnosed with hyperprolactinaemia and. Location: JAPAN , 23 years of age, After Cabergoline was administered, patient had the following side effects: abortion (What is abortion?), pregnancy test false positive.

6315455-5 | Echocardiogram Abnormal
on Aug 07, 2009 Female patient from UNITED KINGDOM , 40 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: echocardiogram abnormal. Cabergoline dosage: 250 Ug, Twice Weekly. Patient was hospitalized.

6288556-8 | Foetal Malposition, Forceps Delivery, Gait Disturbance, Hip Dysplasia, Pregnancy
on Jul 17, 2009 Female patient from UNITED KINGDOM , 27 years of age, was diagnosed with pituitary tumour benign and was treated with Cabergoline (View Usage). Patient had the following side effects: foetal malposition, forceps delivery, gait disturbance, hip dysplasia, pregnancy (What is pregnancy?). Cabergoline dosage: Oral.

6286280-9 | Asthenia, Fall, Somnolence
Patient was taking Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: asthenia, fall (What is fall?), somnolence on Jul 14, 2009 from JAPAN Additional patient health information: Female patient , 58 years of age, was diagnosed with pituitary tumour benign, epilepsy (What is epilepsy?) and. Cabergoline dosage: 0.25 Mg, 1x/day. During the same period patient was treated with VALERIN (200 Mg, 3x/day) (View Valerin Review and Valerin Label ), DEPAKENE (Frequency: 4x/day,) (View Depakene Review and Depakene Label ), ALEVIATIN (56.6 Mg, 3x/day) (View Aleviatin Review and Aleviatin Label ), CORTRIL (Unk) (View Cortril Review and Cortril Label ), THYRADIN (Unk) (View Thyradin Review and Thyradin Label ), METLIGINE (Unk) (View Metligine Review and Metligine Label ), PURSENNID (Unk) (View Pursennid Review and Pursennid Label ). Patient was hospitalized.

6285242-5 | Gait Disturbance, Hip Dysplasia, Pregnancy
Adverse event was reported on Jul 20, 2009 by a Female patient taking Cabergoline (View Usage) (Dosage: ) was diagnosed with pituitary tumour benign and. Location: UNITED KINGDOM , 27 years of age, Patient experienced the following unwanted or unexpected effects: gait disturbance, hip dysplasia, pregnancy (What is pregnancy?).

6269084-2 | Asthenia, Fall, Somnolence
on Jul 15, 2009 Female patient from JAPAN , 58 years of age, was diagnosed with pituitary tumour benign, epilepsy (What is epilepsy?) and was treated with Cabergoline (View Usage). Patient had the following side effects: asthenia, fall (What is fall?), somnolence. Cabergoline dosage: 0.25 Mg, 1x/day. During the same period patient was treated with VALERIN (200 Mg, 3x/day) (View Valerin Review and Valerin Label ), DEPAKENE (Frequency: 4x/day,) (View Depakene Review and Depakene Label ), ALEVIATIN (View Aleviatin Review and Aleviatin Label ), CORTRIL (Unk) (View Cortril Review and Cortril Label ), THYRADIN (Unk) (View Thyradin Review and Thyradin Label ), METLIGINE (Unk) (View Metligine Review and Metligine Label ), PURSENNID (Unk) (View Pursennid Review and Pursennid Label ). Patient was hospitalized.

6267703-8 | Gait Disturbance, Hip Dysplasia
on Jul 02, 2009 Female patient from UNITED KINGDOM , 27 years of age, was diagnosed with pituitary tumour benign and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: gait disturbance, hip dysplasia. Cabergoline dosage: Half A Tablet Weekly.

6255066-3 | Dizziness, Fall, Somnolence
Patient was taking Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), fall (What is fall?), somnolence on Jun 22, 2009 from JAPAN Additional patient health information: Female patient , 58 years of age, was diagnosed with pituitary tumour benign and. Cabergoline dosage: 0.5 Mg, 1x/day. During the same period patient was treated with MIDODRINE HYDROCHLORIDE (View Midodrine Hydrochloride Review and Midodrine Hydrochloride Label ), CORTRIL (View Cortril Review and Cortril Label ), THYRADIN (View Thyradin Review and Thyradin Label ), VALERIN (View Valerin Review and Valerin Label ), DEPAKENE (View Depakene Review and Depakene Label ), ALEVIATIN (View Aleviatin Review and Aleviatin Label ). Patient was hospitalized.

6239338-4 | Blood Prolactin Increased
Adverse event was reported on Jun 10, 2009 by a Female patient taking Cabergoline (View Usage) (Dosage: ) was diagnosed with pituitary tumour benign and. Location: UNITED KINGDOM , 13 years of age, Patient had the following side effects: blood prolactin increased.

6237799-8 | Condition Aggravated, Visual Field Defect
on Jun 04, 2009 Male patient from FRANCE , 64 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: condition aggravated, visual field defect. Cabergoline dosage: 1mg 1x Week. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6237798-6 | Scotoma, Visual Field Defect
on Jun 04, 2009 Male patient from FRANCE , 30 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: scotoma, visual field defect. Cabergoline dosage: 3 Mg 1x Week.

6237797-4 | Hemianopia
Patient was taking Cabergoline (View Usage). Patient had the following side effects: hemianopia on Jun 04, 2009 from FRANCE Additional patient health information: Male patient , 57 years of age, was diagnosed with prolactinoma and. Cabergoline dosage: 3 Mg 1x Week).

6236478-0 | Blood Prolactin Increased
Adverse event was reported on Jun 10, 2009 by a Female patient taking Cabergoline (View Usage) (Dosage: ) was diagnosed with prolactinoma and. Location: UNITED KINGDOM , 14 years of age, After Cabergoline was administered, patient had the following side effects: blood prolactin increased.

6236474-3 | Blood Prolactin Increased
on Jun 10, 2009 Female patient from UNITED KINGDOM , 16 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: blood prolactin increased. Cabergoline dosage: Unk.

6234293-5 | Delusion, Major Depression, Marital Problem, Nausea, Osteopenia, Pathological Gambling
on Jun 01, 2009 Female patient from AUSTRALIA , 38 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient had the following side effects: delusion, major depression, marital problem, nausea (What is nausea?), osteopenia, pathological gambling. Cabergoline dosage: (0.25 Mg 1x/week).

6199358-5 | Blood Glucose Increased, Blood Ph Increased, Bundle Branch Block Right, Cardiac Murmur, Lymphadenopathy, Mitral Valve Incompetence, Nasopharyngitis, Pleural Effusion, Pulmonary Artery Dilatation
Patient was taking Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: blood glucose increased, blood ph increased, bundle branch block right, cardiac murmur, lymphadenopathy, mitral valve incompetence, nasopharyngitis, pleural effusion, pulmonary artery dilatation on May 07, 2009 from SPAIN Additional patient health information: Male patient , 79 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: 2 Mg Oral. During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), METHYLPHENIDATE HCL (View Methylphenidate Hcl Review and Methylphenidate Hcl Label ), RASAGILINE (View Rasagiline Review and Rasagiline Label ). Patient was hospitalized.

6198976-8 | Cardiogenic Shock, Mitral Valve Incompetence
Adverse event was reported on May 19, 2009 by a Female patient taking Cabergoline (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: GERMANY , 75 years of age, Patient experienced the following unwanted or unexpected effects: cardiogenic shock, mitral valve incompetence. Patient was hospitalized.

6195599-1 | Alopecia, Aortic Valve Incompetence, Arrhythmia, Delusion, Dyspnoea, Fatigue, Hypertension, Mitral Valve Incompetence, Oedema Peripheral
on May 13, 2009 Female patient from GERMANY , 79 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient had the following side effects: alopecia, aortic valve incompetence, arrhythmia (What is arrhythmia?), delusion, dyspnoea, fatigue, hypertension, mitral valve incompetence, oedema peripheral. Cabergoline dosage: 4mg Per Day. During the same period patient was treated with NACOM ^DUPONT PHARMA^ (View Nacom ^dupont Pharma^ Review and Nacom ^dupont Pharma^ Label ). Patient was hospitalized.

6168814-8 | Prolonged Labour
on Apr 20, 2009 Female patient from UNITED KINGDOM , weighting 165.0 lb, was diagnosed with hyperprolactinaemia and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: prolonged labour. Cabergoline dosage: .

6146255-7 | Constipation, Face Injury, Heart Rate Irregular, Loss Of Consciousness
Patient was taking Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), face injury, heart rate irregular, loss of consciousness on Mar 25, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 392.4 lb, was diagnosed with pituitary tumour and. Cabergoline dosage: See Image. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ). Patient was hospitalized.

6111683-2 | Abdominal Discomfort, Asthenia, Chest Pain, Confusional State, Dizziness, Fatigue, Fear, Feeling Abnormal, Headache
Adverse event was reported on Mar 10, 2009 by a Female patient taking Cabergoline (View Usage) (Dosage: 1 Tablet Twice A Week Po) was diagnosed with prolactinoma and. Location: UNITED STATES , 45 years of age, weighting 180.0 lb, Patient had the following side effects: abdominal discomfort, asthenia, chest pain (What is chest pain?), confusional state, dizziness (What is dizziness?), fatigue, fear, feeling abnormal, headache (What is headache?).

5999463-X | Abortion Spontaneous
on Dec 05, 2008 Female patient from UNITED KINGDOM , 36 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: abortion spontaneous. Cabergoline dosage: .

5985948-9 | Condition Aggravated, Pituitary Haemorrhage, Tumour Haemorrhage, Visual Acuity Reduced, Visual Pathway Disorder
on Dec 05, 2008 Male patient from BRAZIL , 27 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, pituitary haemorrhage, tumour haemorrhage, visual acuity reduced, visual pathway disorder. Cabergoline dosage: 1.5 Mg/week. Patient was hospitalized.

5985947-7 | Headache, Pituitary Haemorrhage
Patient was taking Cabergoline (View Usage). Patient had the following side effects: headache (What is headache?), pituitary haemorrhage on Dec 05, 2008 from BRAZIL Additional patient health information: Female patient , 15 years of age, was diagnosed with hyperprolactinaemia and. Cabergoline dosage: 1.5 Mg/week. Patient was hospitalized.